Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Adalimumab safe and effective in rheumatoid arthritis

Dec. 11, 2002

Once-weekly dosing of Enbrel supported by phase III study

Dec. 10, 2002

Organon and Entelos expand research collaboration

Dec. 5, 2002

Two series of cytokine production inhibitors with utility in arthritis and heart failure

Dec. 5, 2002

Approvable letter for Pennsaid in Canada

Dec. 4, 2002

New cathepsin inhibitors in early development at Medivir

Dec. 3, 2002

Series of dual PDE7/PDE4 inhibitors covered by BMS patent

Dec. 3, 2002

GW-274150, a selective inhibitor of iNOS, attenuates collagen-induced arthritis in mice

Dec. 3, 2002

FR-167653, a potential antiinflammatory agent

Dec. 2, 2002

Orally active C5a receptor antagonist with potential in inflammatory conditions

Nov. 29, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...